Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bourgeat

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Neurobiology of Aging|May 18, 2010
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of agingChristopher C Rowe, Kathryn A Ellis, Miroslava Rimajova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAzadeh Feizpour, Pierrick Bourgeat, Vincent Dore, et al.
Ebiomedicine|October 22, 2024
Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platformAzadeh Feizpour, James David Doecke, Vincent Doré, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 10, 2026
Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectoriesRodrigo Cánovas, Christopher J Fowler, Azadeh Feizpour, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's ContinuumA Feizpour, V Doré, J D Doecke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPierrick Bourgeat, Jurgen Fripp, Ashley G Gillman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPierrick Bourgeat, Jurgen Fripp, Ashley G Gillman, et al.
Neurobiology of Disease|June 8, 2022
Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-βMarcela Cespedes, Kelly R Jacobs, Paul Maruff, et al.
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Scientific Data|May 19, 2026
Multimodal ultra-high-field MRI, clinical, cognitive, and genetic profiles across the ALS-FTD spectrumThomas B Shaw, Aiman Al Najjar, Markus Barth, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Neurobiology of Aging|May 18, 2010
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of agingChristopher C Rowe, Kathryn A Ellis, Miroslava Rimajova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAzadeh Feizpour, Pierrick Bourgeat, Vincent Dore, et al.
Ebiomedicine|October 22, 2024
Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platformAzadeh Feizpour, James David Doecke, Vincent Doré, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 10, 2026
Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectoriesRodrigo Cánovas, Christopher J Fowler, Azadeh Feizpour, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's ContinuumA Feizpour, V Doré, J D Doecke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPierrick Bourgeat, Jurgen Fripp, Ashley G Gillman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPierrick Bourgeat, Jurgen Fripp, Ashley G Gillman, et al.
Neurobiology of Disease|June 8, 2022
Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-βMarcela Cespedes, Kelly R Jacobs, Paul Maruff, et al.
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Scientific Data|May 19, 2026
Multimodal ultra-high-field MRI, clinical, cognitive, and genetic profiles across the ALS-FTD spectrumThomas B Shaw, Aiman Al Najjar, Markus Barth, et al.
Pageof 26